A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes: Table 1
2016
Diabetes Care
Preserved Fulltext
Table 1 -Proposed glucose levels when reporting hypoglycemia in clinical trials Level 1 A glucose alert value of 3.9 mmol/L (70 mg/dL) or less. This need not be reported routinely in clinical studies, although this would depend on the purpose of the study Level 2 A glucose level of ,3.0 mmol/L (,54 mg/dL) is sufficiently low to indicate serious, clinically important hypoglycemia Level 3 Severe hypoglycemia, as defined by the ADA (6,7) , denotes severe cognitive impairment requiring external assistance for recovery 156 Position Statement
doi:10.2337/dc16-2215
pmid:27872155
fatcat:zrvddvfn55bk7olv2s3wj475qi